Schubert & Co’s Revolution Medicines RVMD Stock Holding History

Schubert & Co’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4	Closed	-$87	–	1216
2023 Q1	$87	Buy	+4	New	+$98	﹤0.01%	1607

Other funds holding RVMD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Schubert & Co's RVMD Position: Q2 2023 in Review

Schubert & Co sold out of Revolution Medicines (RVMD) in Q2 2023, closing a stake of 4 shares — an estimated $87 sold.

Schubert & Co first reported a position in RVMD in Q1 2023 and held it in 1 quarter. The position peaked at $87 in Q1 2023. 139 funds tracked by Wall St. Rank hold RVMD as of Q2 2023.

Schubert & Co reported no remaining Revolution Medicines position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 4 Revolution Medicines shares in Q2 2023, an estimated $87.
Schubert & Co first reported a position in Revolution Medicines in Q1 2023 and held it in 1 quarter.
Schubert & Co's Revolution Medicines position peaked at $87 in Q1 2023.
139 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.